1
DRYJA Thomas, SINGER Michael: MÉTHODES DE TRAITEMENT DE VASCULARITE À LAIDE DUN MOLÉCULE DE LIAISON À LIL-17, METHODS OF TREATING VASCULITIS USING AN IL-17 BINDING MOLECULE. Novartis, DRYJA Thomas, SINGER Michael, FISCHER Leslie, September 20, 2012: WO/2012/125680 (36 worldwide citation)

The disclosure relates to a novel treatment of vasculitis, e.g., giant cell arteritis (GCA), polymyalgia rheumatica (PMR), Wegener's granulomatosis, polyarteritis nodosa, etc., which employs a therapeutically effective amount of an IL-17 binding molecule, e.g., an IL-17 antibody, such as the AIN457 ...


2
John G Curd, Antonio J Grillo Lopez: Treatment of vasculitis. Genentech, Biogen Idec, Wendy M Lee, October 1, 2013: US08545843 (32 worldwide citation)

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


3
Norihiro Nishimoto, Tadamitsu Kishimoto, Hideko Nakahara: Treatment of vasculitis with IL-6 antagonist. Chugai Seiyaku Kabushiki Kaisha, Foley & Lardner, December 31, 2013: US08617550 (4 worldwide citation)

To provide a preventive and/or therapeutic agent for vasculitis such as polyarteritis nodosa, the aortitis syndrome, and a vasculitis that is associated with immunological abnormalities, said agent comprising an interleukin-6 (IL-6) antagonist as an active ingredient.


4
Sandra Verploegen, David P E Satijn, Rene M A Hoet, Paul Parren, Jan Van De Winkel, Vibeke Miller Breinholt, Eva Ehrnrooth, Ole Baadsgaard, Tom Vink, Willem Karel Bleeker, Mischa Houtkamp, Maroeska Oudshoorn, Rob N De Jong: Human antibodies against tissue factor and methods of use thereof. GENMAB, Nelson Mullins Riley & Scarborough, Jane E Remillard Esq, Christopher L Frank, July 25, 2017: US09714297

Isolated human monoclonal antibodies which bind to human TF and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies.


5
Torsten Witte, Niklas Thomas Baerlecken: Methods and means for diagnosing vasculitis. MEDIZINISCHE HOCHSCHULE HANNOVER, Whitham Curtis & Cook P C, March 13, 2018: US09915667

Provided herein are methods for diagnosing the presence or the risk of development, or for the therapy control of vasculitis, in particular of large vessel vasculitis, like giant-cell arteritis (GCA), polymyalgia rheumatica (PMR), and Takayasu's arteritis, in a subject analyzing for the presence of ...


6
Jing Enpu: Chinese medicine "maiguandan" for treatment of vasculitis and its prodn. method. Jing Enpu, ZHAO JIAMIN, August 9, 1995: CN94110790

The Chinese-medicinal "Maiguandan" pill for curing thromboangiitis obliterans with special effect and no by-effect is prepared from 17 Chinese-medicinal materials such as scrophularia root, astragalus root, Japanese honeysuckle flower, ledebouriella root, notopterygium root.


7
Dong Shifeng: Making method of strong thrombus-dissolving capsule. Dong Shifeng, HAN FENGNIAN, April 29, 1992: CN90108331

This invention is related to a fabrication method of medicine for treatment of vasculitis, Large dosages of Chinese angelica, safflower, leech and vomiting nut are made into electrary and pill of chinese medicine with less dosage by technology procedure of Western medicinal preparation. 150 cases of ...


8
Michael J Yellin, Seth Lederman, Leonard Chess, Mihail N Karpusas, David W Thomas: Therapeutic applications for the anti-t-bam (cd40l) monoclonal antibody 5c8 in the treatment of vasculitis. James F Haley Jr, Fish & Neave, May 29, 2003: US20030099642-A1

Activation of cells bearing CD40 on their cell surface by CD40 ligand is inhibited by contacting the cells with an agent capable of inhibiting interaction between CD40 ligand and the cells, in an amount effective to inhibit activation of the cells. Activation of cells bearing CD40 on their surface b ...


9
Zhang Jingshan: Pearl fumigation vascular gutron and preparation thereof. Zhang Jingshan, xubao quan, August 20, 2008: CN200810074144

The invention discloses a pearl fumigation agent used for treating vasculitis, which is prepared with rhubarb, olibanum, myrrh, catnip, safflower and pearl powder in a given weight ratio. The drug has the advantages of functions of heat-clearing and fire-purging, anti-inflaminatory, antibacterial, t ...


10
Zou Lu: Chinese patent medicine capable of dredging collateral. Zou Lu, Shi Weiyi, April 1, 2009: CN200710157339

The invention relates to a Chinese patent medicine for smoothing collaterals, which is mainly used for treating vasculitis. The Chinese patent medicine is prepared by a plurality of Chinese herbal medicines, and the main ingredients are as follows: saffron, cordyceps sinensis, bovine periosteum, tur ...